Stay updated with breaking news from David Pinniger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Amruta Khandekar and Bhanvi Satija (Reuters) - Initial public offerings by small private biotech companies are poised to stage a comeback later in ...
Initial public offerings by small private biotech companies are poised to stage a comeback later in 2023 as the pace of interest rate hikes slows, but tougher economic conditions will make investors
With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.
By Natalie Grover LONDON (Reuters) - With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine...
LONDON (Reuters) - With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.